What Is The Watchman Procedure?

The Watchman procedure is a minimally invasive heart treatment designed to reduce stroke risk in people with a common heart rhythm condition called atrial fibrillation (AFib). It works by permanently closing off a small pouch in the upper left chamber of the heart where blood clots often form. Instead of relying on lifelong blood thinners, the device acts as a physical barrier to keep those clots from traveling to the brain.

Why Do People With AFib Need Stroke Prevention?

Atrial fibrillation causes the upper chambers of the heart to beat irregularly and often too fast. When the atria do not squeeze properly, blood can pool and stagnate. Stagnant blood is more likely to form a clot.

More than 90 percent of stroke-causing clots in people with non-valvular AFib form in a small, ear-shaped sac called the left atrial appendage (LAA). If a clot breaks loose, it can travel through the bloodstream to the brain and block blood flow. That blockage causes an ischemic stroke.

Blood thinners like warfarin or newer anticoagulants reduce this risk by making it harder for blood to clot. They work well, but they come with a cost. These medications increase the risk of serious bleeding, including bleeding in the brain and the digestive tract. Some people cannot tolerate them at all.

What Is The Watchman Procedure Exactly?

The Watchman is a small, parachute-shaped device made of a metal frame and a fabric cover. A doctor delivers it to the heart using a thin tube called a catheter, usually inserted through a vein in the leg.

Under general anesthesia, the doctor guides the catheter up to the heart and into the left atrium. From there, they position the device at the opening of the left atrial appendage and expand it so it fits snugly. Over time, heart tissue grows over the device, completely sealing off the pouch.

The procedure itself typically takes about an hour. Most patients stay in the hospital overnight and go home the next day. Recovery is generally quick, and most people return to normal activities within a week.

Who Is a Candidate for the Watchman?

The Watchman is not for everyone with AFib. It is specifically designed for people with non-valvular AFib, meaning their irregular rhythm is not caused by a problem with the mitral valve.

Candidates usually meet several criteria. They have an elevated stroke risk, which doctors measure using a scoring system that accounts for age, sex, and conditions like high blood pressure, diabetes, or prior stroke. They also have a reason to avoid long-term blood thinners, such as a history of major bleeding or a job or lifestyle that makes bleeding dangerous.

People who do well on blood thinners without side effects generally do not need the Watchman. The device is an alternative, not a replacement, for people who can safely take anticoagulant medication.

Not everyone is anatomically suitable. The size and shape of the left atrial appendage vary from person to person. Some hearts have an appendage that is too large, too small, or shaped in a way that makes device placement unsafe. A doctor will perform imaging tests, usually a transesophageal echocardiogram, to check before scheduling the procedure.

How Effective Is the Watchman Compared to Blood Thinners?

Clinical trials have compared the Watchman directly to warfarin, the standard blood thinner used for decades. The results show that the device is comparable to warfarin for preventing stroke and is better at reducing bleeding complications.

Research published in major cardiology journals has followed patients for several years after implantation. Over the long term, the Watchman reduced the risk of hemorrhagic stroke and major bleeding compared to warfarin. The risk of ischemic stroke was similar between the two approaches.

It is important to understand what “comparable” means. The Watchman does not eliminate stroke risk entirely. People who receive the device still face the same underlying risks from high blood pressure, diabetes, and other conditions. The procedure only addresses the clots that form in the left atrial appendage.

One important detail: patients typically take blood thinners for at least 45 days after the procedure while the device heals and tissue grows over it. After that, most switch to aspirin and sometimes clopidogrel for several months. Eventually, many stop all blood thinners entirely.

What Are the Risks of the Watchman Procedure?

Like any invasive heart procedure, the Watchman carries risks. The most serious complications are rare but real.

During the procedure, there is a small risk of damaging the heart wall, which can cause fluid to collect around the heart. This is called pericardial effusion. In most cases, doctors can drain the fluid with a needle. In rare situations, surgery may be needed.

Stroke can occur during the procedure itself if a clot or air bubble travels to the brain. The risk is low, but it exists. Some patients develop bleeding at the catheter insertion site in the leg. Infection is uncommon but possible.

There is also a risk that the device does not seat properly and needs repositioning. In a small percentage of cases, the device can dislodge and move to another part of the heart. This requires urgent intervention.

After implantation, a blood clot can form on the surface of the device before tissue fully covers it. This is why patients take blood thinners for the first several weeks. The risk drops significantly after the device is fully healed.

What Happens After the Watchman Procedure?

The first follow-up visit usually happens at 45 days. The doctor performs an imaging test to confirm the device is in place and that no blood is leaking around it. If everything looks good, the patient stops taking the stronger blood thinner.

A second check occurs around six months. After that, most patients continue on daily aspirin indefinitely. Some may also take clopidogrel for the first six months, depending on their individual risk profile.

Patients should expect to continue managing their other stroke risk factors. High blood pressure, diabetes, high cholesterol, and smoking all increase stroke risk independently of AFib. The Watchman addresses one source of clots, not all of them.

How Does the Watchman Compare to Other Options?

Blood thinners remain the first-line treatment for most people with AFib and elevated stroke risk. They are highly effective, widely available, and do not require any procedure. The main downside is bleeding risk.

Surgical closure of the left atrial appendage is another option, but it is usually done during heart surgery for another reason, such as a bypass or valve replacement. Standalone surgical closure is more invasive and requires a longer recovery.

Newer devices similar to the Watchman have entered the market in recent years. They work on the same principle but have slightly different designs. Clinical experience with these newer devices is less extensive than with the Watchman.